1. Brenner, D.J., Hall, E.J.: Computed tomography—an increasing source of radiation exposure. N. Engl. J. Med. 357(22), 2277–2284 (2007)
2. Stoessl, A.J.: Developments in neuroimaging: positron emission tomography. Parkinsonism Relat. Disord. 20(20S1), S180–S183 (2014)
3. Beyer, T., Townsend, D.W., Brun, T., Kinahan, P.E., Charron, M., Roddy, R., Jerin, J., Young, J., Byars, L., Nutt, R.: A combined PET/CT scanner for clinical oncology. J. Nucl. Med. 41(8), 1369–1379 (2000)
4. Shankar, L.K., Hoffman, J.M., Bacharach, S., Graham, M.M., Karp, J., Lammertsma, A.A., Larson, S., Mankoff, D.A., Siegel, B.A., Van den Abbeele, A., Yap, J., Sullivan, D.: Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J. Nucl. Med. 47(6), 1059–1066 (2016)
5. FDG-PET/CT Technical Committee: QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy Profile (V 1.05) (2013)